- $143.97m
- $126.39m
- $60.84m
- 87
- 34
- 89
- 81
Annual income statement for Crexendo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16.4 | 28.1 | 37.6 | 53.2 | 60.8 |
| Cost of Revenue | |||||
| Gross Profit | 11.4 | 21.5 | 29.2 | 37.3 | 44.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 14.4 | 30.9 | 74.9 | 54.9 | 59 |
| Operating Profit | 2 | -2.81 | -37.4 | -1.69 | 1.82 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.9 | -2.91 | -36.2 | -0.264 | 1.89 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7.94 | -2.44 | -35.4 | -0.362 | 1.68 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.94 | -2.44 | -35.4 | -0.362 | 1.68 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7.94 | -2.44 | -35.4 | -0.362 | 1.68 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.418 | -0.087 | -0.616 | -0.05 | 0.056 |
| Dividends per Share |